| Item Type | Name |
|
Academic Article
|
Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
|
|
Academic Article
|
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
|
|
Concept
|
Immunohistochemistry
|
|
Academic Article
|
?-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition.
|
|
Academic Article
|
Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation.
|
|
Academic Article
|
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
|
|
Academic Article
|
Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome.
|
|
Academic Article
|
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
|
|
Academic Article
|
An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients.
|
|
Academic Article
|
Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas.
|
|
Academic Article
|
Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas.
|
|
Academic Article
|
Fusion of circulating blood cells with solid-organ tissue cells in clinical stem cell transplants: a potential therapeutic model?
|
|
Academic Article
|
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
|
|
Academic Article
|
Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible.
|
|
Academic Article
|
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.
|
|
Academic Article
|
Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
|
|
Academic Article
|
Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.
|
|
Academic Article
|
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets.
|
|
Academic Article
|
Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.
|
|
Academic Article
|
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
|
|
Academic Article
|
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
|
|
Academic Article
|
Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.
|
|
Academic Article
|
Role of the clinical pathology laboratory in the evaluation of endometrial carcinomas for Lynch syndrome.
|
|
Academic Article
|
Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors.
|
|
Academic Article
|
Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.
|
|
Academic Article
|
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
|
|
Academic Article
|
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
|
|
Academic Article
|
Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
|
|
Academic Article
|
Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.
|
|
Academic Article
|
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
|
|
Academic Article
|
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
|
|
Academic Article
|
Intact PTEN Expression by Immunohistochemistry is Associated With Decreased Survival in Advanced Stage Ovarian/Primary Peritoneal High-grade Serous Carcinoma.
|
|
Academic Article
|
Factors affecting the success of next-generation sequencing in cytology specimens.
|
|
Academic Article
|
Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
|
|
Academic Article
|
Intact PTEN expression by immunohistochemistry is associated with decreased survival in advanced stage ovarian/primary peritoneal high-grade serous carcinoma
|
|
Academic Article
|
Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer
|
|
Academic Article
|
Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
|
|
Academic Article
|
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray.
|
|
Academic Article
|
Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
|
|
Academic Article
|
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
|
|
Academic Article
|
Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.
|
|
Academic Article
|
Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.
|
|
Academic Article
|
Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
|
|
Academic Article
|
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
|
|
Academic Article
|
Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
|